RIPERCOL INJECTABLE DIN 02205947
Status: Cancelled Post Market
Holder: AYERST VETERINARY LABORATORIES
Health Canada record
| Active ingredient(s) | LEVAMISOLE HYDROCHLORIDE (LEVAMISOLE PHOSPHATE) 136.5 MG |
|---|---|
| Dosage form | Liquid |
| Route | Subcutaneous |
| Schedule | PRESCRIPTION |
| Class | Veterinary |
| ATC | |
| Original market date | 16-Nov-1999 |
| Current status date | 14-Aug-2001 |
| Source | Health Canada DPD |
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing LEVAMISOLE HYDROCHLORIDE (LEVAMISOLE PHOSPHATE)
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 00430862 | RIPERCOL INJ 136.5MG/ML | CYANAMID CANADA INC. | Liquid | LEVAMISOLE HYDROCHLORIDE (LEVAMISOLE PHOSPHATE) 136.5 MG | Cancelled Post Market |
| 02202549 | TRAMISOL INJECTABLE | AYERST VETERINARY LABORATORIES | Liquid | LEVAMISOLE HYDROCHLORIDE (LEVAMISOLE PHOSPHATE) 136.5 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 6905 | 1998-01-19 | New Drug Submission (NDS) |